Skip to main content

Advertisement

SpringerLink
Log in

Hormone dependency of breast tumours developing in the Guernsey Cohort Study

  • Epidemiology
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The aim of this study was to determine whether endogenous estradiol levels in postmenopausal women helped determine the estrogen receptor status of subsequent breast cancers. Within the Guernsey Cohort study of 6127 women, 140 have been diagnosed with breast cancer of whom 59 had estradiol assays performed and ER status available. Estradiol levels in serum and urine were measured by radioimmunoassay and ER status of tumours by immunohistochemistry. Of the individuals in the highest tertile of serum estradiol 35% had ER+ve tumours compared with 27% in the lowest tertile. In terms of 16hydroxyestrone excretion the proportions ER+ve tumours were 22% in the lowest tertile and 38% in the highest tertile. This suggests that endogenous estrogen levels do impact on the phenotype of subsequent breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bulbrook RD, Hayward JL, Spicer CC, et al. (1962) Abnormal excretion of urinary steroids by women with early breast cancerLancet ii:1238–1240

    Article  Google Scholar 

  2. Thomas HV, Key T, Allen DS, et al. (1997) A prospective study of endogenous serum hormone concentrations and breast cancer risk in postmenopausal women on the island of GuernseyBr J Cancer 76:901–905

    Google Scholar 

  3. Collaborative Group on Hormonal Factors in Breast Cancer. (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancerLancet 350:1047–1059

    Article  Google Scholar 

  4. Jones C, Ingram D, Mattes E, et al. (1994) The effect of hormone replacement therapy on prognostic indices in women with breast cancerMed J Aus 161:106–110

    CAS  Google Scholar 

  5. Magnusson C, Holmberg L, Norden T, et al. (1996) Prognostic characteristics in breast cancers after hormone replacement therapyBreast Cancer Res Treat 38: 325–334

    Article  PubMed  CAS  Google Scholar 

  6. Li CI, Daling JR, Malone KE. (2003) Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998J Clin Oncol 21:28–34

    Article  PubMed  CAS  Google Scholar 

  7. Gruvberger S, Ringner M, Chen Y, et al. (2001) Estrogen receptor status in breast cancer is associated with remarkably different gene expression patternsCancer Res 61:5979–5984

    PubMed  CAS  Google Scholar 

  8. Fentiman IS, Wang DY, Allen DS, et al. (1994) Bone density of normal women in relation to endogenous and exogenous oestrogensBr J Rheumatol 33:808–815

    Article  PubMed  CAS  Google Scholar 

  9. Key TJA, Wang DY, Brown JB, et al. (1996) A prospective study of urinary oestrogen excretion and breast cancer riskBr J Cancer 73:1615–1619

    PubMed  CAS  Google Scholar 

  10. Thomas HV, Key TJ, Allen DS, et al. (1997) A prospective study of endogenous serum hormone concentrations and breast cancer risk on the Island of GuernseyBr J Cancer. 76: 401–405

    PubMed  CAS  Google Scholar 

  11. Al Saati T, Clamens S, Cohen-Kanafo E, et al. (1993) Production of monoclonal antibodies to human oestrogen receptor protein (ER) using recombinant ER (RER)Int J Cancer 55:651–65

    Article  PubMed  CAS  Google Scholar 

  12. Miyoshi Y, Tanji Y, Taguchi T, et al. (2003) Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese womenClin Cancer Res 9: 2229–2233

    PubMed  CAS  Google Scholar 

  13. Zeleniuch-Jacquotte A, Toniolo P, Levitz M, et al. (1995) Endogenous estrogens and risk of breast cancer: a prospective study in postmenopausal women. Cancer Epidemiol Biomarkes Prev 4:857–860

    CAS  Google Scholar 

  14. Nomura Y, Tashiro H, Hamada Y, et al. (1987) Relationship between estrogen receptors and risk factors of breast cancer in Japanese pre- and postmenopausal patientsBreast Cancer Res Treat 4:37–43

    Article  Google Scholar 

  15. Giuffrida D, Lupo L, La Porta GA, Padova G, Foti E, Marchese V. (1992) Relation between steroid receptor status and body weight in breast cancer patientsEur J Cancer 28:112–115

    Article  PubMed  CAS  Google Scholar 

  16. Harlan LC, Coates RJ, Block G, et al. (1993) Estrogen receptor status and dietary intakes in breast cancer patientsEpidemio 4: 25–31

    Article  CAS  Google Scholar 

  17. Kushi LH, Potter JD, Bostick RM, Drinkard CR, Sellers TA, et al. (1995) Dietary fat and risk of breast cancer according to hormone receptor statusEpidemiol Biomarkers Prev 4:11–19

    CAS  Google Scholar 

  18. Mannisto S, Pietinen P, Pyy M, et al. (1996) Body-size indicators and risk of breast cancer according to menopausal and estrogen receptor statusInt J Cancer 27:8–13

    Article  Google Scholar 

  19. Enger SM, Ross RK, Paganini-Hill A, et al. (2000) Body size, physical activity, and breast cancer hormone receptor status: results from 2 case-control studiesCancer Epidemiol Biomarkers Prev 9:681–687

    PubMed  CAS  Google Scholar 

  20. Hildreth NG, Kelsey JL, Eisenfeld AJ, et al. (1983) Differences in breast cancer risk factors according to the estrogen receptor level of the tumorJ Natl Cancer Inst 70:1037–1031

    Google Scholar 

  21. Stanford JL, Szklo M, Boring CC, et al. (1987) A case-control study of breast cancer stratified by estrogen receptor statusAm J Epidemiol 125:184–194

    PubMed  CAS  Google Scholar 

  22. Li CI, Malone KE, Daling JR. (2002) Differences in breast cancer hormone receptor status and histology by race and histology by race and ethnicity among women 50 years of age and olderCancer Epidemiol Biomarkers Prev 11:601–607

    PubMed  Google Scholar 

  23. Yoo KV, Tajima K, Miura S, Yoshida M, Kuroishi T, et al. (1993) A hospital-based case-control study of breast cancer risk factors by estrogen and progesterone receptor statusCancer Causes Control 4:39–44

    Article  PubMed  CAS  Google Scholar 

  24. Gapstur SM, Potter JD, Drinkard C, Folsom AR. (1995) Cancer Epidemiol Biomarkers Prev 4:313–318

    CAS  Google Scholar 

  25. Potter JD, Cerhan JR, Sellers TA, McGovern PG, Drinkard C, et al. (1995) Progesterone and estrogen receptors and mammary neoplasia in the Women’s Health Study: how many kinds of breast cancer are there?Cancer Epidemiol Biomarkers Prev 4:319–326

    PubMed  CAS  Google Scholar 

  26. Tutera AM, Sellers TA, Potter JD, Drinkard CR, Wiesner GL, Folsom AR. (1996) Association between family history of cancer and breast cancer defined by estrogen and progesterone receptor statusGenet Epidemiol 13: 207–221

    Article  PubMed  CAS  Google Scholar 

  27. Enger SM, Ross RK, Paganini-Hill A, et al. (1999) Alcohol consumption and breast cancer oestrogen and progesterone receptor statusBr J Cancer 78:1308–1314

    Article  Google Scholar 

  28. Althuiss MD, Fergenbaum JH, Garcia-Closas M, et al. (2004) Etiology of hormone receptor-defined breast cancer: a systematic review of the literatureCancer Epidemiol Biomarkers Prev 13:1558–1568

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hedley Atkins Breast Unit, Guy’s Hospital, London, UK

    I.S. Fentiman & D.S. Allen

  2. Academic Department of Pathology, University of Leeds, Leeds, UK

    A. Hanby

  3. CRUK Epidemiology Unit, Gibson Building, Radcliffe Hospital, Oxford , UK

    T. Key & E.N. Meilahn

  4. Academic Oncology, Guy’s Hospital, 3rd Floor Thomas Guy House, SE1 9RT, London, UK

    I.S. Fentiman

Authors
  1. I.S. Fentiman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Hanby
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D.S. Allen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Key
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E.N. Meilahn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I.S. Fentiman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fentiman, I., Hanby, A., Allen, D. et al. Hormone dependency of breast tumours developing in the Guernsey Cohort Study. Breast Cancer Res Treat 97, 205–208 (2006). https://doi.org/10.1007/s10549-005-9113-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-005-9113-8

Keywords

Search

Navigation